Sophie Busson, Ph.D
About Sophie Busson, Ph.D
Sophie Busson, Ph.D, is a Preclinical Development Research Scientist II at MeiraGTx in London, England. She holds a Ph.D. from UCL and has previous experience in various roles, including as a Clarks Trained Fitter and Sales Advisor.
Current Role at MeiraGTx
Sophie Busson, Ph.D., serves as a Preclinical Development Research Scientist II at MeiraGTx in London, England. She has held this position since 2021, contributing to the company's research initiatives in gene therapy and molecular development. Her role involves conducting preclinical studies and supporting the advancement of therapeutic candidates through the development pipeline.
Previous Experience at MeiraGTx
Prior to her current role, Sophie Busson worked at MeiraGTx as an MSAT Molecular Development Scientist from 2020 to 2021. In this capacity, she focused on the manufacturing science and technology aspects of molecular development, contributing to the optimization of processes and ensuring compliance with regulatory standards.
Education and Expertise
Sophie Busson completed her Doctor of Philosophy (PhD) at University College London (UCL) from 2016 to 2019. Her academic journey began with a Bachelor's Degree from UCL, which she obtained from 2013 to 2016. This educational background has equipped her with a strong foundation in scientific research and development, particularly in the field of molecular biology.
Early Career Background
Before entering the scientific field, Sophie Busson gained experience in retail. She worked as a Sales Advisor at Debenhams from 2010 to 2014, where she developed customer service skills. Additionally, she briefly worked as a Clarks Trained Fitter in 2016 for three months in Hemel Hempstead, United Kingdom, further diversifying her professional experience.
High School Education
Sophie Busson completed her high school education at John F. Kennedy RC Secondary School from 2005 to 2012. This foundational education set the stage for her subsequent academic pursuits in higher education.